RecruitingNCT07465523
A Novel Approach in the Evaluation of Breast Masses With Doppler US
A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation
Sponsor
Ahmet Yesildag
Enrollment
90 participants
Start Date
Mar 4, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria3
- Those with solid breast masses
- Female patients
- Those with pathology results
Exclusion Criteria3
- Hypovascular masses
- Cystic breast masses
- Cases with mastitis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07465523
Related Trials
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
NCT0541751627 locations
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
NCT030964182 locations
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
NCT035244307 locations
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
NCT068922751 location
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
NCT033233461 location